Home » Newsletters » BioWorld

BioWorld

Sep. 15, 1999

View Archived Issues

Appointments and Advancements

Idun Raises More Than $7M To Fund Work For Two Years

Other News To Note

Alliance Gets OK From FDA On Design Of Phase III Trial

New Chemical Entities, Thetagen Merge To Focus On Drug Leads

Zonagen Cuts Staff Following Delay In Vasomax Development